menu ☰
menu ˟

Generics and Biosimilars Initiative Journal

Title Added Edit View
2018/4 GaBI Journal Table of Contents 28 Jan 2019 edit view
Fourth and final issue of GaBI Journal’s seventh volume 28 Jan 2019 edit view
2018/3 GaBI Journal Table of Contents 07 Jan 2019 edit view
US generic prescription drug markets 2004‒2016 19 Dec 2018 edit view
How does generic drug policy affect market prices? 03 Dec 2018 edit view
Latest features in GaBI Journal, 2018, Issue 3 03 Dec 2018 edit view
2018/2 GaBI Journal Table of Contents 05 Sep 2018 edit view
What to look forward to in GaBI Journal, 2018, Issue 2 27 Aug 2018 edit view
EU risk-sharing agreements between 2000−2015 10 Jul 2018 edit view
Biocomparable Drugs in Mexico: Challenges and Opportunities in the Treatment of Gaucher Disease 10 Jul 2018 edit view
Implementing a treatment registry for a biosimilar: continuous safety surveillance of the biosimilar Bevax® (bevacizumab) in Argentina 10 Jul 2018 edit view
First ASEAN educational workshop on regulation and approval of biosimilars/similar biotherapeutic products 2017 – Report 14 Jun 2018 edit view
Biosimilar regulation and approval in Jordan 14 Jun 2018 edit view
Medicines regulation in the Middle East and the importance of the World Health Organization’s INN proposal of Biological Qualifier 14 Jun 2018 edit view
A call for coherence in EU legislation to promote generics 01 Jun 2018 edit view
In vitro analytical and antibiotic comparison of generic medicine of Moxifloxacin against E. coli and S. aureus bacteria strains 01 Jun 2018 edit view
Rationalizing FDA guidance on biosimilars—expediting approvals and acceptance 01 Jun 2018 edit view
Regulation of copy biologicals in China 06 Apr 2018 edit view
2018/1 GaBI Journal Table of Contents 05 Apr 2018 edit view
Editor’s introduction to the initial issue of the seventh volume of GaBI Journal 21 Feb 2018 edit view
Barriers to generics policy reform: a US case study 02 Feb 2018 edit view
Biosimilar infliximab introduction into the gastroenterology care pathway in a large acute Irish teaching hospital: a story behind the evidence 19 Jan 2018 edit view
Patent expiry dates for biologicals: 2017 update 19 Jan 2018 edit view
The impact of religion on human embryonic stem cell regulations: comparison between the UK, Germany and the US 19 Jan 2018 edit view
Quality assessment of biosimilars in Colombia – reducing knowledge gaps 19 Jan 2018 edit view